Regulation
NET Recovery wins FDA breakthrough tag for psychostimulant addiction device
NET Recovery received FDA Breakthrough Device designation for a neurostimulation device designed to treat psychostimulant addiction by reducing cravings in patients with stimulant use disorder. The designation expedites the device's regulatory pathway.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network